• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Transl Med . Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study

tetano

Editor, Senior Moderator
J Transl Med


. 2020 Dec 7;18(1):461.
doi: 10.1186/s12967-020-02655-8.
Risk factors for severe COVID-19 in middle-aged patients without comorbidities: a multicentre retrospective study


Peng Wang[SUP] 1 [/SUP], Jing Sha[SUP] 1 [/SUP], Mei Meng[SUP] 2 [/SUP], Cuiyan Wang[SUP] 3 [/SUP], Qingchun Yao[SUP] 1 [/SUP], Zhongfa Zhang[SUP] 4 [/SUP], Wenqing Sun[SUP] 5 [/SUP], Xingguang Wang[SUP] 6 [/SUP], Guoqiang Qie[SUP] 1 [/SUP], Xue Bai[SUP] 1 [/SUP], Keke Liu[SUP] 7 [/SUP], Yufeng Chu[SUP] 8 [/SUP]



Affiliations

Abstract

Background: Information regarding characteristics and risk factors of COVID-19 amongst middle-aged (40-59 years) patients without comorbidities is scarce.
Methods: We therefore conducted this multicentre retrospective study and collected data of middle-aged COVID-19 patients without comorbidities at admission from three designated hospitals in China.
Results: Among 119 middle-aged patients without comorbidities, 18 (15.1%) developed into severe illness and 5 (3.9%) died in hospital. ARDS (26, 21.8%) and elevated D-dimer (36, 31.3%) were the most common complications, while other organ complications were relatively rare. Multivariable regression showed increasing odds of severe illness associated with neutrophil to lymphocyte ratio (NLR, OR, 11.238; 95% CI 1.110-1.382; p < 0.001) and D-dimer greater than 1 ?g/ml (OR, 16.079; 95% CI 3.162-81.775; p = 0.001) on admission. The AUCs for the NLR, D-dimer greater than 1 ?g/ml and combined NLR and D-dimer index were 0.862 (95% CI, 0.751-0.973), 0.800 (95% CI 0.684-0.915) and 0.916 (95% CI, 0.855-0.977), respectively. SOFA yielded an AUC of 0.750 (95% CI 0.602-0.987). There was significant difference in the AUC between SOFA and combined index (z = 2.574, p = 0.010).
Conclusions: More attention should be paid to the monitoring and early treatment of respiratory and coagulation abnormalities in middle-aged COVID-19 patients without comorbidities. In addition, the combined NLR and D-dimer higher than 1 μg/ml index might be a potential and reliable predictor for the incidence of severe illness in this specific patient with COVID-19, which could guide clinicians on early classification and management of patients, thereby relieving the shortage of medical resource. However, it is warranted to validate the reliability of the predictor in larger sample COVID-19 patients.

Keywords: COVID-19; Coronavirus; Middle-aged; Risk factors; SARS-CoV-2.
 
Back
Top Bottom